DC50292A Tablet

· Heronova Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DC50292A Tablet, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors [Phase 1]